Rare diseases
Investigational molecules
Locations
Back to Italy249 clinical trials in Novara, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Abatacept for Predicting Treatment Response in Patients with Early Rheumatoid Arthritis
ItalyStudy on Tedopi and Nivolumab for Patients with Advanced Non-Small Cell Lung Cancer After Initial Treatment
ItalyStudy of Vemurafenib and Rituximab for Untreated Hairy Cell Leukemia Patients
ItalyStudy on Olaparib for Maintenance Therapy in Patients with Newly Diagnosed Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer
ItalyStudy of TP-3654 and Momelotinib for Patients with Intermediate or High-risk Myelofibrosis
ItalyStudy on Elacestrant and Everolimus for Patients with Advanced ER+/HER2- Breast Cancer Resistant to Endocrine Therapy and CDK4/6 Inhibitors
ItalyStudy on Cannabis Extract for Improving Quality of Life in Patients with Alzheimer's, Parkinson's, or ALS Using Dronabinol and Cannabidiol
ItalyStudy of Ibrutinib for Treating Autoimmune Hemolytic Anemia in Patients with Chronic Lymphocytic Leukemia or Similar Conditions
ItalyStudy of Venetoclax, Ibrutinib, and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia
ItalyStudy of Atezolizumab with Drug Combination for Patients with Unresectable Metastatic Colorectal Cancer
ItalyStudy of Pembrolizumab and MK-2870 for Patients with Metastatic Squamous Non-small Cell Lung Cancer
ItalyStudy on Long-Term Safety of Pelabresib for Patients with Myelofibrosis or Essential Thrombocythemia
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on hematologic malignancies and solid tumors, investigating innovative treatments for various cancer types including leukemia, breast cancer, and lung cancer.
Studies evaluating combination therapies and targeted treatments to improve patient outcomes.
Research focusing on heart failure prevention and treatment strategies, particularly exploring new drug combinations and their impact on cardiovascular outcomes.
Innovative approaches combining multiple therapeutic agents to address cardiovascular risks.
Investigations into treatments for various autoimmune disorders, including Sjögren's Syndrome and rheumatoid arthritis, with emphasis on novel therapeutic approaches.
Focus on developing targeted therapies for better disease management and patient care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
